Researchers identify two risk factors that indicate higher risk of aggressive prostate cancer

FHS
July 11, 2024
12:31 pm

A recent European Urology Oncology study assessed the mortality risks, based on the Gleason score and clinical parameters, in patients with prostate cancer.

Comanche raises $75m to develop preeclampsia therapy

Share this article Preeclampsia is persistent high blood pressure that develops during the second trimester of pregnancy or up to six weeks following delivery. Image

January 18, 2024

Apple pauses sales of latest watches in the U.S. after ITC decision

Apple is temporarily pulling certain Apple Watches from the U.S. market to comply with an import ban issued by the International Trade Commission in October.

December 18, 2023

Targeting intracellular checkpoints to enhance NK cell immunotherapy

Natural killer (NK) cells are pivotal in the innate immune response against cancer and viral infections, with their presence in tumors correlating to better patient

November 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.